Congenital defects of glycosylation: Novel presentations with mainly neurological involvement and variable dysmorphic features
- 7 May 2021
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 185 (9) , 2739-2747
Abstract
The pathophysiology of congenital defects of glycosylation (CDG) is complex and the diagnosis has been a challenge because of the overlapping clinical signs and symptoms as well as a large number of disorders. Isoelectric focusing of transferrin has been used as a screening method but has limitations. Individual enzyme or molecular genetic tests have been difficult to perform. In this study, we aimed to describe CDG patients who were referred to from different departments either without a preliminary diagnosis or suspected to have a genetic disorder other than CDG. The patients were diagnosed mainly with a 450 gene next‐generation DNA sequencing panel for inborn errors of metabolism, which also included 25 genes for CDG. A total of 862 patients were investigated with the panel, whereby homozygous (10) or compound heterozygous (4) mutations were found in a total of 14 (1.6%) patients. A total of 13 different mutations were discovered, 10 of them being novel. Interestingly, none of the patients was suspected to have a CDG before referral. This report expands the clinical/laboratory findings in patients with CDG and stresses on the fact that CDG should be in the differential list for pediatric patients presented with nonspecific dysmorphic features and neurological delays/regression. Also, next‐generation DNA sequencing with panel approach was noticed to have a significant diagnostic potential in patients presented with nonspecific neurologic and dysmorphic findings.Keywords
This publication has 17 references indexed in Scilit:
- Solving Glycosylation Disorders: Fundamental Approaches Reveal Complicated PathwaysThe American Journal of Human Genetics, 2014
- Defining the Phenotype in Congenital Disorder of Glycosylation Due to ALG1 MutationsPediatrics, 2012
- SRD5A3-CDG: A patient with a novel mutationEuropean Journal of Paediatric Neurology, 2012
- Clinical and diagnostic approach in unsolved CDG patients with a type 2 transferrin patternBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Integrative genomics viewerNature Biotechnology, 2011
- Congenital disorders of glycosylationAnnals of the New York Academy of Sciences, 2010
- Golgi function and dysfunction in the first COG4-deficient CDG type II patientHuman Molecular Genetics, 2009
- Brain involvement in muscular dystrophies with defective dystroglycan glycosylationAnnals of Neurology, 2008
- Phenotypes of Patients with “Simple” Mendelian Disorders Are Complex Traits: Thresholds, Modifiers, and Systems DynamicsThe American Journal of Human Genetics, 2000
- Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13 in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome)Nature Genetics, 1997